Scilex Holding Co (SCLX)
0.9054
+0.04
(+4.07%)
USD |
NASDAQ |
May 17, 16:00
0.938
+0.03
(+3.60%)
After-Hours: 20:00
Scilex Cash from Investing (Quarterly): -0.15M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.15M |
| December 31, 2023 | -0.167M |
| September 30, 2023 | -0.155M |
| June 30, 2023 | -0.008M |
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.007M |
| June 30, 2022 | -2.06M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.06M
Minimum
Jun 2022
--
Maximum
Dec 2022
-0.3184M
Average
-0.079M
Median
Cash from Investing (Quarterly) Benchmarks
| Sorrento Therapeutics Inc | -0.14M |
| Adial Pharmaceuticals Inc | 0.35M |
| Precision BioSciences Inc | -0.026M |
| Humacyte Inc | -0.391M |
| Perspective Therapeutics Inc | -47.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.391M |
| Cash from Financing (Quarterly) | -11.20M |
| Free Cash Flow | -4.052M |
| Free Cash Flow Per Share (Quarterly) | 0.0902 |
| Free Cash Flow to Equity (Quarterly) | 25.46M |
| Free Cash Flow to Firm (Quarterly) | 9.772M |
| Free Cash Flow Yield | -3.74% |